ESMO Preceptorship on Brain Tumours 2022: Lugano

Slides and Webcasts from all ESMO Preceptorships are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties.

Learning objectives

• To learn about the evidence base for diagnostic imaging, molecular pathology and neurocognitive assessment in brain tumor patients
• To understand the basis of multi-modality treatment of lower and higher-grade gliomas
• To learn about local and systemic treatment options for meningiomas
• To learn about the multi-modality management of brain metastasis patients including targeted therapies in patients with actionable driver mutations and with novel immunotherapies
• To learn about future developments in the management of gliomas, meningiomas, brain metastases and leptomeningeal carcinomatosis